This week, Jeremy talks to Calaneet Balas, President and CEO of The ALS Association about the approval of RELYVRIO, formerly known as AMX0035, for the treatment of ALS and looks ahead to the fight for access to this and other ALS treatments in the pipeline.

Learn more about RELYVRIO at https://www.als.org/navigating-als/living-with-als/fda-approved-drugs/amx0035

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.